Jeff Wells, PharmD, MBA
Glaukos Corporation
5
0
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jay Katz, MD
Wills Eye Institute; Thomas Jefferson University
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey L Goldberg, MD PhD
Stanford University
Shared therapeutic areas:
Malik Y. Kahook, MD
Rocky Mountain Lions Eye institute
Shared therapeutic areas:
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
Gerhard Garhöfer, MD
Department of Clinical Pharmacology, Medical University of Vienna
Shared therapeutic areas:
Michelle Chen, PhD
Allergan
Shared therapeutic areas:
Jaime Dickerson, PhD
Sight Sciences, Inc.
Shared therapeutic areas:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
Leopoldo Baiza Durán, MD
Laboratorios Sophia S.A de C.V.
Shared therapeutic areas:
Ahmed A Tabl, MD
Benha University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma
A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma
Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)
GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma
Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort
All 5 trials loaded